[{"Assets_0_Q3_USD":"595070000.0","CIK":"1628171","CommonStockSharesConverted_0_Q3_shares":"66324753.0","CommonStockSharesOutstanding_0_Q3_shares":"66324753.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.42","EarningsPerShareBasic_3_Q3_USD":"-1.49","Industry":"Specialty Chemicals","Market":"NASDAQ","Market Cap":"1775342076.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-75030000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-27221000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"-76174000.0","NetIncomeLoss_1_Q3_USD":"-27221000.0","NetIncomeLoss_3_Q3_USD":"-73955000.0","OfficialName":"Revolution Medicines Inc. Common Stock","ProfitLoss_3_Q3_USD":"-73955000.0","RevenuesConverted_1_Q3_USD":"12661000.0","RevenuesConverted_3_Q3_USD":"34232000.0","SP500":null,"Sector":"Consumer Durables","StockholdersEquity_0_Q3_USD":"505070000.0","Ticker":"RVMD","filed":"20201112","footnote":null,"form":"10-Q","fp":"Q3","fy":"2020.0","name":"REVOLUTION MEDICINES, INC.","period":"20200930","qtrs":"1","uom":"USD"}]